Neoadjuvant chemotherapy after liver transplantation for hepatocellular carcinoma

Transplant Proc. 1994 Dec;26(6):3568-9.
No abstract available

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Carcinoma, Hepatocellular / drug therapy*
  • Carcinoma, Hepatocellular / mortality
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / surgery
  • Chemotherapy, Adjuvant
  • Doxorubicin / therapeutic use*
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppression Therapy
  • Liver Neoplasms / drug therapy*
  • Liver Neoplasms / mortality
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery
  • Liver Transplantation* / mortality
  • Male
  • Middle Aged
  • Recurrence
  • Retrospective Studies
  • Survival Rate
  • Time Factors
  • alpha-Fetoproteins / analysis

Substances

  • alpha-Fetoproteins
  • Doxorubicin